BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 742500)

  • 1. Motility of the pathogen and intestinal immunity of the host in experimental cholera.
    Yancey RJ; Berry LJ
    Adv Exp Med Biol; 1978; 107():447-55. PubMed ID: 742500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flagella-induced immunity against experimental cholera in adult rabbits.
    Yancey RJ; Willis DL; Berry LJ
    Infect Immun; 1979 Jul; 25(1):220-8. PubMed ID: 478635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection and immunity to Vibrio cholerae, Salmonella typhimurium and Escherichia coli in a rabbit model.
    Guinée PA; Jansen WH; Rijpkema SG
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 270(1-2):260-9. PubMed ID: 2464884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholera and the immune response.
    Holmgren J; Svennerholm AM
    Prog Allergy; 1983; 33():106-19. PubMed ID: 6338509
    [No Abstract]   [Full Text] [Related]  

  • 5. Vibrio cholerae infection and acquired immunity in an adult rabbit model.
    Guinée PA; Jansen WH; Peters PW
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Feb; 259(1):118-31. PubMed ID: 4002931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
    Kundu J; Mazumder R; Srivastava R; Srivastava BS
    FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental research on cholera vaccines. Local immunity].
    Manakhilov RB; Genova IuG; Bogatinov VT; Kostova EF
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Oct; (10):59-62. PubMed ID: 3799104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitoxic immunity in experimental cholera: protection, and serum and local antibody responses in rabbits after enteral and parenteral immunization.
    Holmgren J; Svennerholm AM; Ouchterlony O; Anderson A; Walletström G; Westerberg-Berndtsson U
    Infect Immun; 1975 Dec; 12(6):1331-40. PubMed ID: 54337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vibrio cholerae and cholera: out of the water and into the host.
    Reidl J; Klose KE
    FEMS Microbiol Rev; 2002 Jun; 26(2):125-39. PubMed ID: 12069878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraduodenal inoculation of adult rabbits for evaluating the immunogenicity of genetically attenuated Vibrio cholerae strains.
    García Imia L; Oliva Hernández R; Cedré Marrero B; Valmaseda Pérez T; García Sánchez H; Talavera Coronel A; Pérez Quiñoy JL; Sierra González G
    Lab Anim Sci; 1998 Oct; 48(5):538-41. PubMed ID: 10090073
    [No Abstract]   [Full Text] [Related]  

  • 11. [The immunology of cholera and the molecular biology of cholera toxin. Recent progress and future perspectives].
    Carrada-Bravo T
    Rev Alerg Mex; 1994; 41(3):69-76. PubMed ID: 9377108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphology.
    Levinson KJ; De Jesus M; Mantis NJ
    Infect Immun; 2015 Apr; 83(4):1674-83. PubMed ID: 25667263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective immunity against Vibrio cholerae infection in the rabbit.
    Guinée PA; Jansen WH; Gielen H; Rijpkema SG; Peters PW
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Oct; 266(3-4):552-62. PubMed ID: 2964158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A monoclonal antibody that targets the conserved core/lipid A region of lipopolysaccharide affects motility and reduces intestinal colonization of both classical and El Tor Vibrio cholerae biotypes.
    Levinson KJ; Baranova DE; Mantis NJ
    Vaccine; 2016 Nov; 34(48):5833-5836. PubMed ID: 27773473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of motility in experimental cholera in adult rabbits.
    Yancey RJ; Willis DL; Berry LJ
    Infect Immun; 1978 Nov; 22(2):387-92. PubMed ID: 730361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunity Provided by an Outer Membrane Vesicle Cholera Vaccine Is Due to O-Antigen-Specific Antibodies Inhibiting Bacterial Motility.
    Wang Z; Lazinski DW; Camilli A
    Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Live Attenuated Cholera Vaccine CVD 103-HgR Primes Responses to the Toxin-Coregulated Pilus Antigen TcpA in Subjects Challenged with Wild-Type Vibrio cholerae.
    Mayo-Smith LM; Simon JK; Chen WH; Haney D; Lock M; Lyon CE; Calderwood SB; Kirkpatrick BD; Cohen M; Levine MM; Gurwith M; Harris JB
    Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27847368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.
    Liao J; Gibson JA; Pickering BS; Watnick PI
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation into immunological responses against a native recombinant CTB whole-cell Vibrio cholerae vaccine in a rabbit model.
    Boustanshenas M; Bakhshi B; Ghorbani M
    J Appl Microbiol; 2013 Feb; 114(2):509-15. PubMed ID: 23082752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cumulative protective efficacy of rZot and rAce combination in challenge experiments with wild type Vibrio cholerae in mouse model.
    Anvari S; Najar-Peerayeh S; Behmanesh M; Bakhshi B
    Hum Vaccin Immunother; 2018; 14(9):2323-2328. PubMed ID: 29852089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.